CN1840101A - Chinese medicine with wind-dispelling damp-eliminating, collaterals-dredging, coldness-expelling pain-relieving functions and preparation process thereof - Google Patents
Chinese medicine with wind-dispelling damp-eliminating, collaterals-dredging, coldness-expelling pain-relieving functions and preparation process thereof Download PDFInfo
- Publication number
- CN1840101A CN1840101A CNA2006100456857A CN200610045685A CN1840101A CN 1840101 A CN1840101 A CN 1840101A CN A2006100456857 A CNA2006100456857 A CN A2006100456857A CN 200610045685 A CN200610045685 A CN 200610045685A CN 1840101 A CN1840101 A CN 1840101A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- cinnabaris
- chinese medicine
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese pharmaceutical composition for dispersing pathogenic wind, removing dampness, relaxing meridianal system, dispersing cold and relieving pain, which is prepare from 24 kinds of Chinese medicinal herbs including prepared Sichuan aconite root, dahurian angelica root, prepared wild aconite root, cyperus tuber, licorice root, white atractylodes rhizome, myrrh, Chinese ephedra, Ligusticum wallichii, frankincense, large-leaf gentian root, earthworm, Chinese angelica root, poria cocos, red phaseolus bean, notopterygium root, gastrodia tuber, radix paeoniae rubrathe, asaryl, ledebouriella root, arisaema tuber, cassia twig, spikenard and cinnabar.
Description
Technical field
The present invention relates to a kind of Chinese medicine and preparation technology thereof, particularly relate to a kind of Chinese medicine and preparation technology with expelling wind and removing dampness, the meridian dredging, dispersing cold for relieving pain function.
Technical background
" rheumatism " is one of modal frequently-occurring disease clinically, it is " arthromyodynia " that the traditional Chinese medical science claims this sick, be meant because exopathogen invasion and attack human bodies such as wind, cold, wet, heat, the impatency passages through which vital energy circulates, QI-blood circulation is not smooth to be caused, even with muscle, muscles and bones, joint ache, numb, weighing, the joint stuffiness arthroncus is scorching hot is the disease of main clinical manifestation.Rheumatic arthralgia class disease incidence height, the drug market capacity is big.Have data to show that rheumatic arthralgia class disease accounts for about 10% of outpatient service total number of persons, this quantity is the sickness rate that is only second to respiratory tract, digestive tract, cardiovascular system diseases.
The western medical treatment rheumatism is mainly used nonsteroidal anti-inflammatory analgetic and hormone medicine treatment at present, and is bigger to the side effect of human body.The rheumatism Western medicine is divided into and improves the symptom medicine and improve state of an illness medicine.Improve the symptom medicine and mainly be meant anti-inflammation analgesia medicine, this class medicine can be controlled patient's pain, swelling rapidly, but can not stop the development of the state of an illness.Improving state of an illness medicine effect characteristics is that onset is slow, onset in common 1 month, and reaching the curative effect peak needs six months, it is generally acknowledged this type of medicine may command active rheumatism.All there is gastrointestinal side effect in various degree in the rheumatism Western medicine, even hepatic and renal function injure, gonad inhibition, erythra etc. occur.
Compare Western medicine, Chinese medicine has its distinctive feature in treatment, the Chinese traditional treatment rheumatism has a long history, and has formed complete theoretical system from ancient times to the present gradually, ancient Chinese medicine doctor has been formulated abundant effectively treatment side's medicine, becomes current rheumatologist's precious resources.Because the property of medicine of Chinese herbal medicine is gentle, side effect is little, is subjected to chronic disease patients' such as rheumatism welcome deeply.But the Chinese medicine for the treatment of rheumatism at present also exists not enoughly alleviating on the arthralgia, bring certain misery when giving patient treatment, and is still waiting further not improve aspect the erythrocyte sedimentation rate improving.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of Chinese medicine and preparation technology with expelling wind and removing dampness, the meridian dredging, dispersing cold for relieving pain function at the problems referred to above, it is to symptom determined curative effects such as arthralgia, neck and shoulder pain, lumbago and backache, myalgia, numb limbs and tense tendons, its taking convenience, effect easily absorbs rapidly, good analgesic effect and fast, action temperature and and lasting, toxic and side effects is less, and it is better that the patient accepts the toleration of long-term treatment, effective to the improvement of erythrocyte sedimentation rate.
Medicament selection Radix Aconiti Preparata of the present invention, the Radix Angelicae Dahuricae, Radix Aconiti Kusnezoffii Preparata, Rhizoma Cyperi, Radix Glycyrrhizae, the Rhizoma Atractylodis Macrocephalae, Myrrha, Herba Ephedrae, Rhizoma Chuanxiong, Olibanum, Radix Gentianae Macrophyllae, Pheretima, Radix Angelicae Sinensis, Poria, Semen Phaseoli, Rhizoma Et Radix Notopterygii, Rhizoma Gastrodiae, Radix Paeoniae Rubra, Herba Asari, Radix Saposhnikoviae, Rhizoma Arisaematis, Ramulus Cinnamomi, Radix Et Rhizoma Nardostachyos, 24 kinds of medicines of Cinnabaris make up, make each efficacy of drugs produce synergism these drug regimens, thereby can effectively treat rheumatism.
The consumption of drug component of the present invention be through the inventor carry out a large amount of grope to sum up with experimentation draw, the weight ratio of each raw material all has curative effect preferably in following weight range.
In order to solve the problems of the technologies described above, the present invention is achieved in that to have expelling wind and removing dampness, the meridian dredging, the Chinese medicine of dispersing cold for relieving pain function, the raw material of making effective ingredient constitutes by weight: Radix Aconiti Preparata 50-150, Radix Angelicae Dahuricae 50-150, Radix Aconiti Kusnezoffii Preparata 50-150, Rhizoma Cyperi 50-150, Radix Glycyrrhizae 50-150, Rhizoma Atractylodis Macrocephalae 30-80, Myrrha 10-50, Herba Ephedrae 50-150, Rhizoma Chuanxiong 50-150, Olibanum 30-80, Radix Gentianae Macrophyllae 30-80, Pheretima 50-150, Radix Angelicae Sinensis 30-80, Poria 150-250, Semen Phaseoli 50-150, Rhizoma Et Radix Notopterygii 50-150, Rhizoma Gastrodiae 30-80, Radix Paeoniae Rubra 50-150, Herba Asari 50-150, Radix Saposhnikoviae 30-80, Rhizoma Arisaematis 50-150, Ramulus Cinnamomi 30-80, Radix Et Rhizoma Nardostachyos 30-80, Cinnabaris 60-130.
Described Chinese medicine, the raw material of making effective ingredient constitutes by weight: Radix Aconiti Preparata 80-120, Radix Angelicae Dahuricae 80-120, Radix Aconiti Kusnezoffii Preparata 80-120, Rhizoma Cyperi 80-120, Radix Glycyrrhizae 80-120, Rhizoma Atractylodis Macrocephalae 30-80, Myrrha 10-30, Herba Ephedrae 80-120, Rhizoma Chuanxiong 80-120, Olibanum 30-80, Radix Gentianae Macrophyllae 30-80, Pheretima 80-120, Radix Angelicae Sinensis 30-80, Poria 160-220, Semen Phaseoli 80-120, Rhizoma Et Radix Notopterygii 80-120, Rhizoma Gastrodiae 30-80, Radix Paeoniae Rubra 80-120, Herba Asari 80-120, Radix Saposhnikoviae 30-80, Rhizoma Arisaematis 80-120, Ramulus Cinnamomi 30-80, Radix Et Rhizoma Nardostachyos 30-80, Cinnabaris 60-130.
Described Chinese medicine, the raw material of making effective ingredient constitutes by weight: Radix Aconiti Preparata 100, the Radix Angelicae Dahuricae 100, Radix Aconiti Kusnezoffii Preparata 100, Rhizoma Cyperi 100, Radix Glycyrrhizae 100, the Rhizoma Atractylodis Macrocephalae 50, Myrrha 20, Herba Ephedrae 100, Rhizoma Chuanxiong 100, Olibanum 50, Radix Gentianae Macrophyllae 50, Pheretima 100, Radix Angelicae Sinensis 50, Poria 200, Semen Phaseoli 100, Rhizoma Et Radix Notopterygii 100, Rhizoma Gastrodiae 50, Radix Paeoniae Rubra 100, Herba Asari 100, Radix Saposhnikoviae 50, Rhizoma Arisaematis 100, Ramulus Cinnamomi 50, Radix Et Rhizoma Nardostachyos 50, Cinnabaris 80.
Above-mentioned Chinese medicine preparation technology with expelling wind and removing dampness, the meridian dredging, dispersing cold for relieving pain function comprises the steps: Cinnabaris is ground into impalpable powder, and is standby; Standby after the Rhizoma Atractylodis Macrocephalae parch; Standby after Rhizoma Arisaematis, Myrrha, Rhizoma Cyperi, the Olibanum process of preparing Chinese medicine; Except that Cinnabaris all the other 23 flavor crude drug, wherein the Rhizoma Atractylodis Macrocephalae is after the parch, Rhizoma Arisaematis, Myrrha, Rhizoma Cyperi, Olibanum be for after concocting, put in the agitator tank fully mix homogeneously after, be ground into thin medicated powder with pulverizer, standby; Mel after overbakingization is poured in the holding vessel, sedimentation 12-24 hour Mel is through coarse filtration and fine straining, pump in the vacuum concentration pan, steam pressure is that 0.05-0.15Mpa, vacuum are that 0.08-0.09Mpa, temperature 50-60 ℃ vacuum concentration is standby to tender honey, and the water content of tender honey is 18.5-19.5%; Purified water is heated in the dosing bucket boils, and adds the tender honey of 1-1.5 times of purified water weight, is stirred to mix homogeneously, be heated to boil refined honey, add refined honey 30-50g with every 100g medicated powder and squeeze ball, usefulness Cinnabaris fine powder coating drying.
Describedly be: the crowded pill of institute is packed in the clean dried dish with Cinnabaris fine powder coating drying process, every dish loading amount is even, thickness is no more than 3cm, room temperature is placed and is changed in the heated-air circulation oven again after 35-60 hour, at dry 20-24 below 60 ℃ hour, make moisture≤11.0%, take out and to drop into again in the coating machine, regulate coating machine rotating speed and spray into purified water and make in right amount and be sprinkled into the Cinnabaris powder behind the pill surface wettability and make the pill color and luster even.
Advantage of the present invention and effect are: medicine of the present invention has deep effect, and deep finger penetrates muscles and bones, finds multiple abscess inlet air, cold, wet three kinds of pathogens; Medicine of the present invention also has the wind action of chasing after, and chases after wind and refers to these three kinds of pathogens are forced out rapidly external, and its purpose reaches exactly and chases after the deep and analgesic therapy of wind and smooth vim and vigour and pacify positive effect.Medicine of the present invention and at all times experience good recipe theoretical according to Chinese medicine " control wind and control blood earlier, blood sector-style from go out ", merges that modern science and technology is refining to form at medical materials such as selected Radix Aconiti Kusnezoffii Preparata, Radix Aconiti Preparata, Pheretima, Rhizoma Gastrodiae, Radix Angelicae Sinensis, Rhizoma Chuanxiong.Radix Aconiti Preparata in the medicine of the present invention, Radix Aconiti Kusnezoffii Preparata, Ramulus Cinnamomi, Herba Asari are wet through collateral dredging and pain relieving, and the Radix Angelicae Dahuricae, Radix Gentianae Macrophyllae, Radix Saposhnikoviae, notopterygium wind dispelling win wet and exempt from numbness; According to the theory of the traditional Chinese medical science " control wind and control blood earlier, the blood sector-style is from going out ", so invigorate blood circulation with Chinese Angelica blood replonishing again in the component; Rhizoma Chuanxiong, Rhizoma Cyperi, Radix Paeoniae Rubra nourish blood circulation of qi promoting and the passages through which vital energy circulates that relaxes, whole same usefulness of all medicines of component, and treating both the principal and secondary aspects of a disease becomes the Chinese medicine that the insensitive impediment chronic disease is controlled in effective treatment.Medicine of the present invention is to symptom determined curative effects such as arthralgia, neck and shoulder pain, lumbago and backache, myalgia, numb limbs and tense tendons.Medicine of the present invention is a Chinese medicine preparation, has expelling wind and removing dampness, dredge the meridian passage, the effect of dispersing cold for relieving pain.Product taking convenience safety of the present invention, rapid, the easily absorption of effect.Its herbal medicine efficacy action temperature and and lasting, toxic and side effects is less, and it is better that the patient accepts the toleration of long-term treatment; Medicine of the present invention is a herbal mixture, and it integrates regulating action by multipath, too many levels, the performance of many target spots, can carry out wholistic therapy at rheumatismal a plurality of pathology links; Can improve patient's general situation, health invigorating delays PD, prevents and improves bone destruction, promotes patient's quality of life.Medicine good analgesic effect of the present invention and fast, effective to the improvement of erythrocyte sedimentation rate.
Below further set forth the beneficial effect of medicine of the present invention by clinical experiment.
Clinical drug trial of the present invention is summed up:
Preface: this medicine is made up of 24 kinds of Chinese medicines such as Olibanum, Myrrha, Radix Angelicae Sinensis, Radix Paeoniae Rubra, Radix Saposhnikoviae, Ramulus Cinnamomi, Herba Ephedrae, Radix Aconiti Preparata, the Rhizoma Atractylodis Macrocephalae (stir-fry), Radix Gentianae Macrophyllae, Rhizoma Arisaematiss, function with expelling wind and removing dampness, the meridian dredging, dispersing cold for relieving pain mainly contains diseases such as being used for rheumatism numbness pain, limbs joint pain, numb limbs and tense tendons.Shenyang Inst. of Traditional Chinese Medicine, the 7th the People's Hospital, Shenyang City, the 9th the People's Hospital, Shenyang City is entrusted by Shenyang Chinese Medicine Pharmaceutical Co., Ltd, in calendar year 2001 February-2002 year January this kind is carried out the security verification of clinical efficacy and medication.Non-at random blind method is adopted in clinical trial, observes 400 examples altogether, test group 300 examples wherein, matched group 100 examples.The total effective rate 89% of test group, more obvious effective rate 45.33%; Matched group total effective rate 83%; More curative effect there was no significant difference relatively between 37%, two group of obvious effective rate.But the arthralgia symptom is improved test group apparently higher than matched group, the test group of improving of erythrocyte sedimentation rate also is higher than matched group.
Physical data: on sex, all have comparability before the harmony of the course of disease, the state of an illness, the treatment before the harmony that age distribution before test group and the selected patient's of matched group the treatment, the course of disease distribute, the treatment.
Research method:
One, case choice criteria
(1) diagnostic criteria
1. Western medicine diagnose standard
(1) rheumatic arthritis diagnostic criteria
Work out this standard according to " the clinical guidance principle of new Chinese medicine treatment numbness disease " relevant diagnostic criteria.
1. clinical manifestation: acute stage, have multiple and the migration joint aches, mostly occurs in big joint, can be with redness pain or tuberosity or erythema; Chronicly can only feel joint aches.
2. laboratory examination: anti-" O " is more than 1: 500; Or erythrocyte sedimentation rate speeds; Or more than antistreptokinase 80 units; Or antihyaluronidase is more than 128 units; Or the c reactive protein positive; Or normal person.
3. the rheumatic arthritis medical history was arranged in the past.
(2) cold rheumatoid joint pain diagnostic criteria
This standard is worked out in conjunction with the standard of diagnostic criteria and in April, 1988 whole nation combination of Chinese and Western medicine rheumatism disease academic conference revision in Chinese and Western that " rheumatic four diseases " worked out according to 1985 " rheumatism tremble with fear sick academic forum " is unified.
1. medical history: rheumatism it is attacked by the cold and evil history is arranged.
2. symptom: some joint or muscle are miserable, numb, pain or severe pain, movable difficulty; Meet cold or Changes in weather (cloudy day, rain, the blow) state of an illness increases the weight of.
3. sign: the joint of getting involved is limited because of movable function due to the pain, but alleviates after the activity.Most cases are the pain pneumonedema only, the minority case in the joint around mild swelling.
4. lab testing: erythrocyte sedimentation rate is most normal, and minority is fast slightly; Anti-chain " O ", rheumatoid factor and routine blood test all belong to normally.
5. X ray examination: except that the visible soft tissue swelling of minority case, generally do not have sclerotin change, hyperosteogeny can take place in some cases.
6. prognosis: deformity is not stayed in the joint of getting involved after catabasis or the healing, and joint function recovery is normal.
2. Chinese medical discrimination typing standard:
Work out this standard according to " the clinical guidance principle of new Chinese medicine treatment numbness disease " with the Chinese medical discrimination typing standard of " practical Chinese Internal Medicine " relevant numbness disease.
Cold temperature resistance network card:
Primary symptom: limbs joint pain
Inferior disease: 1. local send out cool, 2. pain increase in intensity under coldness, 3. heavy, the 4. arthroncus of limbs, 5. pale tongue or purple secretly, 6. tongue fur in vain, 7. stringy and tense pulse or heavy.
Possess primary symptom and time 3 of diseases and can establish the pattern of syndrome diagnosis.
3. test the case standard:
(1) include the case standard in:
All Western medicine diagnose standard and TCM Syndrome Type standards of meeting, the patient of age different sexes between 18～65 years old all can be as the experimental observation case.
(2) get rid of the case standard:
1. the limbs joint pain that causes such as rheumatoid arthritis, osteoarthritis.
2. merge serious primary disease of the heart, cerebrovascular, liver, kidney and hemopoietic system and psychotic.
3. the age is at under-18s or over-65s, gestation, prepares gestation or women breast-feeding their children.
4. not medication in accordance with regulations can't be judged that curative effect or data are not congruent to affect the treatment and safety judgement person.
Two, clinic observation index:
(1) safety observation index:
1. general physical examination project (body temperature, blood pressure, pulse, breathing etc.).
2. blood, urine, just routine and electrocardiogram, hepatic and renal function inspection.
3. untoward reaction and toxic and side effects.
(2) health giving quality observation index:
1. observe limbs joint pain before and after the treatment, locally send out cold, pain increase in intensity under coldness, limbs are heavy and the situation of change of symptom such as tongue arteries and veins, sign.
2. anti-chain " O ", rheumatoid factor, erythrocyte sedimentation rate detect.
3. antistreptokinase, antihyaluronidase, c reactive protein detect.
4.X the line sclerotin detects.
Three, test and observation administrated method:
(1) test method and grouping: adopt at random, contrast, polycentric test method carry out clinical trial.Adopt the random digit method at random.Test group 300 examples (wherein rheumatic arthritis 90 examples, cold rheumatoid joint pain 210 examples), matched group 100 examples (wherein rheumatic arthritis 30 examples, cold rheumatoid joint pain 70 examples).Bear the clinical experimental study task by three tame hospitals.
(2) observe administrated method: the test group case is all thrown medicine of the present invention, a 6g, and 2 times on the one, warm water takes.The matched group case is all thrown XIAOHUOLUO WAN (Shenyang Traditional Chinese Medicine Factory produces, lot number 20010108), one time 1 pill, 2 times on the one.4 weeks were a course of treatment, observed a course of treatment.Stopping using during the course of treatment, other has the medicine of therapeutical effect.
Four, curative effect determinate standard:
(1) tcm syndrome (symptom, sign) score standard:
1. limbs joint pain: no limbs joint pain 0 minute; How when activity, to feel pain 2 minutes slightly; Pain is acute, but still can stand 4 fens; Pain (cold type of pain or twinge) acutely unbearably very then dare not be movable 6 minutes.
2. local cool: do not have local cold 0 minute of sending out; The part has cool sense 1 minute slightly; Local cool sense is comparatively obvious, rapidly disappears 2 fens but meet the cool sense of heat; Local creeping chill is obvious, meets the cool sense of heat and disappears slower 3 minutes.
3. pain increase in intensity under coldness: meeting cold pain does not increase by 0 fen; Meet cold pain and increase by 1 fen slightly; Meet comparatively obvious 2 minutes of cold pain increase; Meet very obvious 3 minutes of cold pain increase.
4. limbs are heavy: heavy 0 minute of no limbs; Limbs have sense of heaviness slightly, but do not influence movable 1 minute; Limbs are heavy, movable 2 minutes of minimal effect; Limbs are heavy obviously, and activity also is subjected to obviously influencing 3 fens.
5. picture of the tongue: normal 0 minute; Unusual 1 minute.
6. pulse condition: normal 0 minute; Unusual 1 minute.
(2) state of an illness weight standard:
1. slight: symptom integral≤9 minute.
2. moderate: symptom integral 10～16 minutes.
3. severe: symptom integral 〉=17 minute.
(3) criterion of therapeutical effect:
1. clinical recovery: clinical symptoms (sign) all disappears, and it is normal that the tongue arteries and veins recovers, and integration is zero.
2. produce effects: face and answer symptom (sign) obviously to alleviate, integrated value descended 〉=2/3 before the treatment back was treated.
3. progressive: clinical symptoms (sign) alleviates, and integrated value descended＜2/3, 〉=1/3 before treated the treatment back.
4. invalid: clinical symptoms (sign) nothing is obviously improved or is increased the weight of, and the treatment back preceding integrated value of treatment descends＜1/3.
Therapeutic outcome:
One, two groups of general curative effects are relatively:
By table 1 as seen, the test group total effective rate is 89%; The total effective rate of matched group is 83%.The analysis showed that two groups of there was no significant difference P＞0.05 through Ridit.
Table 1 liang group general curative effect relatively
| Group | The example number | Clinical recovery N (%) | Produce effects N (%) | Effective N (%) | Invalid N (%) | Total effective rate (%) |
| Test group | 300 | 56(18.67) | 80(26.67) | 131(43.66) | 33(11.0) | 89.0 |
| Matched group | 100 | 13(13.00) | 24(24.00) | 46(46.00) | 17(17.00) | 83.0 |
Ridit analyzes: two groups relatively: u=1.76 P＞0.05
Two, two groups of tcm symptoms, sign curative effects compare:
Table 2 is respectively organized every tcm symptom, sign curative effect relatively
| Symptom and sign | Group | The example number | Before the treatment | After the treatment | In the group | |||||||
| +++ | ++ | + | - | +++ | ++ | + | - | u | p | |||
| Arthralgia is local, and to send out cool the heavy chance of limbs cold aches and increase | Test group control group test group control group test group control group test group control group | 300 100 300 100 300 100 300 100 | 68 21 110 35 86 33 108 27 | 142 44 137 45 98 32 124 30 | 90 35 45 16 100 28 59 25 | 0 0 8 4 16 7 9 18 | 6 5 10 5 6 7 12 4 | 38 17 43 15 43 12 50 13 | 134 48 131 41 101 38 117 35 | 122 30 116 39 150 43 121 48 | 14.73 6.72 15.49 8.28 13.43 6.99 14.38 5.88 | ＜0.01 ＜0.01 ＜0.01 ＜0.01 ＜0.01 ＜0.01 ＜0.01 ＜0.01 |
Ridit analyzes: compare between test group and matched group:
Arthralgia: u=2.06 p＜0.05
Local cool: u=0.21 p＞0.05
Pain increase in intensity under coldness: u=1.19 P＞0.05
Limbs are heavy: u=1.22 p＞0.05
As shown in Table 2, no matter test group, matched group all has most of symptoms, sign obviously to alleviate effect, before and after the treatment in the group relatively, difference P＜0.01 of highly significant is all arranged.Carry out between two groups of test group and matched groups treatment back curative effect more relatively, two groups have significant difference p＜0.05 on arthralgia, to two groups of there are no significant difference P＞0.05 in the improvement of other symptom, sign.
Three, test group rheumatic arthritis and cold rheumatoid joint pain clinical curative effect analysis:
As known from Table 3, total efficient of rheumatic arthritis is 86.67%, cure-remarkable-effectiveness rate 34.44%; The cold arthritic total efficient of rheumatism is 90%, cure-remarkable-effectiveness rate 50%; The analysis showed that through Ridit two groups have significant difference P＜0.05.
Table 3 rheumatic arthritis and cold rheumatoid joint pain clinical efficacy are relatively
| The sick kind | The example number | Clinical recovery N (%) | Produce effects N (%) | Effective N (%) | Invalid N (%) | Total effective rate (%) |
| The rheumatic arthritis cold rheumatoid joint pain | 90 210 | 12(13.33) 44(20.95) | 19(21.11) 61(29.05) | 47(52.22) 84(40.00) | 12(13.34) 21(10.00) | 86.67 90.00 |
Ridit analyzes: two groups relatively: u=2.23 p＜0.05
Four, two groups of treatment front and back picture of the tongues, pulse conditions change relatively:
Picture of the tongue, pulse condition change relatively before and after each group treatment of table 4
| Project | Group | The example number | Before the treatment | After the treatment | X 2 | P | ||
| Normally | Unusually | Normally | Unusually | |||||
| The picture of the tongue pulse condition | Test group matched group test group matched group | 300 100 300 100 | 79 25 77 20 | 221 75 223 80 | 200 62 193 58 | 100 38 107 42 | 96.473 26.366 89.057 28.773 | ＜0.01 ＜0.01 ＜0.01 ＜0.01 |
X
2Analyze or the direct probability method analysis of Fisher:
Two groups relatively: picture of the tongue X
2=0.531 P＞0.05
Pulse condition X
2=1.030 P＞0.05
As shown in Table 4, each is organized before and after the treatment of tongue, arteries and veins in the group relatively, and significant difference P＜0.01 is all arranged, and treatment back test group and matched group compare picture of the tongue, pulse condition there are no significant difference P＞0.05.
Five, the change of two groups of treatment front and back detection indexs:
As shown in Table 5, relatively, test group has significant difference P＜0.01, compares there was no significant difference P＞0.05 before and after the treatment of control group in the group of each group anti-" O " treatment front and back, and treatment back test group and matched group be there was no significant difference P＞0.05 relatively.Relatively, significant difference P＜0.01 is arranged in the group of test group erythrocyte sedimentation rate treatment front and back, compare there was no significant difference P＞0.05 before and after the treatment of control group, treatment back test group and matched group relatively have significant difference P＜0.05.Each is organized before and after the c reactive protein treatment in the group relatively, there are no significant difference P＞0.05, and treatment back test group and matched group be there was no significant difference P＞0.05 more also.
Change relatively before and after each group treatment of table 5
| Symptom and sign | Group | The example number | Before the treatment | After the treatment | In the group |
| Normally | Unusually | Normally | Unusually | u | p | |||
| Anti-" O " c reactive protein erythrocyte sedimentation rate | Test group control group test group control group test group control group | 90 30 60 30 90 30 | 19 8 7 9 20 3 | 71 22 53 21 70 27 | 42 15 12 11 48 9 | 48 15 48 19 42 21 | 12.002 2.538 1.001 0.075 17.23 2.604 | ＜0.01 ＞0.05 ＞0.05 ＞0.05 ＜0.01 ＞0.05 |
Compare between group: anti-" O " X
2=0.011 P＞0.05
C reactive protein X
2=2.110 P＞0.05
Erythrocyte sedimentation rate X
2=4.021 P＜0.05
Safety detects:
In the clinical experiment test group has been carried out routine blood test, routine urinalysis, liver function, kidney function test treatment respectively, had in the 3 routine routine blood tests WBC higher before the treatment, treated back 1 routine person and recover normally, other 2 examples are still higher; Also have 3 routine WBC person on the low side, treatment back 2 examples recover normal; 1 example is still on the low side.The improvement of WBC may be relevant with application antibiotic and antiviral drugs.It is unusual to treat preceding 3 routine routine urinalysis, urine protein (±) in the 2 example urine wherein, no change still after the treatment; 1 routine glucose in urine (±) is treated back glucose in urine (-).There are 8 examples to have mild cerebral ischemic to change before electrocardiogram is treated, still do not have significant change after the treatment.Other safeties there is no unusually before and after detecting the index treatment.The 2 examples conscious stomach discomfort in back of taking medicine is arranged, do not have to feel sick, vomiting, advise its after the meal drug administration symptom alleviate to some extent, without other processing, also stopped treatment not the results are shown in Table 6.
Security inspection (N) before and after the treatment of table 6 test group
| Project | The example number | Before the treatment | After the treatment | ||
| Normally | Unusually | Normally | Unusually | ||
| The routine blood test routine urinalysis is routine electrocardiogram GPT BUN just | 250 250 250 200 200 200 | 244 247 200 192 200 200 | 6 3 0 8 0 0 | 248 247 200 192 200 200 | 2 3 0 8 0 0 |
| Cr | 200 | 200 | 0 | 200 | 0 |
Conclusion: medicine of the present invention is treated the total effective 89% of cold dampness accumulation pattern numbness disease clinically, and more obvious effective rate is 45.33%, and various symptoms, the sign of improving cold dampness accumulation pattern numbness disease all had obvious effect, especially obviously is better than matched group on the arthralgia improving.And anti-O and erythrocyte sedimentation rate to rheumatic arthritis also have certain regulating action.Regulating action to erythrocyte sedimentation rate is better than matched group.Except that the minority case is had the slight gastrointestinal symptoms, during medication, take the dosage of regulation, do not see other toxic and side effects, be treatment cold dampness accumulation pattern arthralgia safe and effective medicine.
The specific embodiment
Embodiment one
Medicine of the present invention is made up of Radix Aconiti Preparata 50g, Radix Angelicae Dahuricae 50g, Radix Aconiti Kusnezoffii Preparata 50g, Rhizoma Cyperi 50g, Radix Glycyrrhizae 50g, Rhizoma Atractylodis Macrocephalae 30g, Myrrha 10g, Herba Ephedrae 50g, Rhizoma Chuanxiong 50g, Olibanum 30g, Radix Gentianae Macrophyllae 30g, Pheretima 50g, Radix Angelicae Sinensis 30g, Poria 150g, Semen Phaseoli 50g, Rhizoma Et Radix Notopterygii 50g, Rhizoma Gastrodiae 30g, Radix Paeoniae Rubra 50g, Herba Asari 50g, Radix Saposhnikoviae 30g, Rhizoma Arisaematis 50g, Ramulus Cinnamomi 30g, Radix Et Rhizoma Nardostachyos 30g, Cinnabaris 60g;
The preparation technology who is made into pill is as follows: Cinnabaris is ground into impalpable powder, and standby; Standby after the Rhizoma Atractylodis Macrocephalae parch; Standby after Rhizoma Arisaematis, Myrrha, Rhizoma Cyperi, the Olibanum process of preparing Chinese medicine; Except that Cinnabaris all the other 23 flavor crude drug, wherein the Rhizoma Atractylodis Macrocephalae is after the parch, Rhizoma Arisaematis, Myrrha, Rhizoma Cyperi, Olibanum be for after concocting, put in the agitator tank fully mix homogeneously after, be ground into thin medicated powder with pulverizer, standby; Mel after overbakingization is poured in the holding vessel, sedimentation 12-24 hour Mel is through coarse filtration and fine straining, pump in the vacuum concentration pan, extremely tender honey is standby for steam pressure 0.05-0.15Mpa, vacuum 0.08-0.09Mpa, temperature 50-60 ℃ vacuum concentration, the water content of tender honey is 18.5-19.5%; Purified water is heated in the dosing bucket boils, and adds the tender honey of 1-1.5 times of purified water weight, is stirred to mix homogeneously, be heated to boil refined honey, add refined honey 30-50g with every 100g medicated powder and squeeze ball, usefulness Cinnabaris fine powder coating drying.
Embodiment two
Medicine of the present invention is made up of Radix Aconiti Preparata 150g, Radix Angelicae Dahuricae 150g, Radix Aconiti Kusnezoffii Preparata 150g, Rhizoma Cyperi 150g, Radix Glycyrrhizae 150g, Rhizoma Atractylodis Macrocephalae 80g, Myrrha 50g, Herba Ephedrae 150g, Rhizoma Chuanxiong 150g, Olibanum 80g, Radix Gentianae Macrophyllae 80g, Pheretima 150g, Radix Angelicae Sinensis 80g, Poria 250g, Semen Phaseoli 150g, Rhizoma Et Radix Notopterygii 150g, Rhizoma Gastrodiae 80g, Radix Paeoniae Rubra 150g, Herba Asari 150g, Radix Saposhnikoviae 80g, Rhizoma Arisaematis 150g, Ramulus Cinnamomi 80g, Radix Et Rhizoma Nardostachyos 80g, Cinnabaris 130g;
The preparation technology who is made into pill is as follows: Cinnabaris is ground into impalpable powder, and standby; Standby after the Rhizoma Atractylodis Macrocephalae parch; Standby after Rhizoma Arisaematis, Myrrha, Rhizoma Cyperi, the Olibanum process of preparing Chinese medicine; Except that Cinnabaris all the other 23 flavor crude drug, wherein the Rhizoma Atractylodis Macrocephalae is after the parch, Rhizoma Arisaematis, Myrrha, Rhizoma Cyperi, Olibanum be for after concocting, put in the agitator tank fully mix homogeneously after, be ground into thin medicated powder with pulverizer, standby; Mel after overbakingization is poured in the holding vessel, sedimentation 12-24 hour Mel is through coarse filtration and fine straining, pump in the vacuum concentration pan, extremely tender honey is standby for steam pressure 0.05-0.15Mpa, vacuum 0.08-0.09Mpa, temperature 50-60 ℃ vacuum concentration, the water content of tender honey is 18.5-19.5%; Purified water is heated in the dosing bucket boils, the tender honey that adds 1-1.5 times of purified water weight, be stirred to mix homogeneously, be heated to boil refined honey, add refined honey 30-50g with every 100g medicated powder and squeeze ball, with Cinnabaris fine powder coating drying, with Cinnabaris fine powder coating drying process be: the crowded pill of institute is packed in the clean dried dish, every dish loading amount is even, and thickness is no more than 3cm, and room temperature is placed and changed in the heated-air circulation oven again after 35-60 hour, at dry 20-24 below 60 ℃ hour, make moisture≤11.0%, take out and to drop into again in the coating machine, regulate coating machine rotating speed and spray into purified water and make in right amount and be sprinkled into the Cinnabaris powder behind the pill surface wettability and make the pill color and luster even.
The processing procedure of Rhizoma Arisaematis is as follows: get clean Rhizoma Arisaematis, be soaked in water respectively by size, change water every day 2～3 times, when playing foam, add Alumen after changing water, every 100kg Rhizoma Arisaematis adds Alumen 2kg, steep after one day, change water again, taste to cutting opening and littlely take out when numb feeling in the tongue is arranged.With ginger slice, Alumen put add suitable quantity of water in the pot and boil after, pour into when Rhizoma Arisaematis boils to the no dried heart altogether and take out, remove Rhizoma Zingiberis, cool to four to sixty percent do shave, drying.Wherein every 100kg Rhizoma Arisaematis is with Rhizoma Zingiberis Recens, each 12.5kg of Alumen.
The stir-frying-technology of the Rhizoma Atractylodis Macrocephalae is as follows: the processed with honey wheat bran is sprinkled in the heat pot, adds Rhizoma Atractylodis Macrocephalae sheet when waiting to smolder, fry to coke yellow, effusion burnt odor gas, take out, sieve removes the processed with honey wheat bran.Wherein every 100kg Rhizoma Atractylodis Macrocephalae sheet is with processed with honey wheat bran 10kg.
The processing procedure of Rhizoma Cyperi is as follows: gets Rhizoma Cyperi grain (sheet), mixes thoroughly with vinegar, and vexed, put in the pot, when frying the degree of extremely stipulating, take out, cool.Except as otherwise herein provided, the clean medical material of every 100kg vinegar 20kg can add the suitable quantity of water dilution in case of necessity.
The processing procedure of Olibanum is as follows:
(1) get clean Olibanum, mix thoroughly with vinegar, vexed, put in the pot, when frying, take out to surface-brightening, cool.Every 100kg vinegar 5kg.
(2) get clean Olibanum, put in the heat pot, when frying to surface-brightening, take out, cool with slow fire.Need the parching to brown person, generally fry to surperficial coke yellow with moderate heat, the section color is deepened to be degree, takes out, and cools; Inflammable medical material behind the parching to brown, can spray clear water a little, fry to do again or dry.
The processing procedure of Myrrha is as follows:
(1) get clean Myrrha, mix thoroughly with vinegar, vexed, put in the pot, when frying, take out to surface-brightening, cool.Every 100kg Myrrha vinegar 5kg.
(2) get clean Myrrha, put in the heat pot, when frying to surface-brightening, take out, cool with slow fire.Need the parching to brown person, generally fry to surperficial coke yellow with moderate heat, the section color is deepened to be degree, takes out, and cools; Inflammable medical material behind the parching to brown, can spray clear water a little, fry to do again or dry.
Embodiment three
Medicine of the present invention is made up of Radix Aconiti Preparata 80g, Radix Angelicae Dahuricae 80g, Radix Aconiti Kusnezoffii Preparata 80g, Rhizoma Cyperi 80g, Radix Glycyrrhizae 80g, Rhizoma Atractylodis Macrocephalae 30g, Myrrha 10g, Herba Ephedrae 80g, Rhizoma Chuanxiong 80g, Olibanum 30g, Radix Gentianae Macrophyllae 30g, Pheretima 80g, Radix Angelicae Sinensis 30g, Poria 160g, Semen Phaseoli 80g, Rhizoma Et Radix Notopterygii 80g, Rhizoma Gastrodiae 30g, Radix Paeoniae Rubra 80g, Herba Asari 80g, Radix Saposhnikoviae 30g, Rhizoma Arisaematis 80g, Ramulus Cinnamomi 30g, Radix Et Rhizoma Nardostachyos 30g, Cinnabaris 60g; Its preparation technology is with embodiment one.
Embodiment four
Medicine of the present invention is made up of Radix Aconiti Preparata 120g, Radix Angelicae Dahuricae 120g, Radix Aconiti Kusnezoffii Preparata 120g, Rhizoma Cyperi 120g, Radix Glycyrrhizae 120g, Rhizoma Atractylodis Macrocephalae 80g, Myrrha 30g, Herba Ephedrae 120g, Rhizoma Chuanxiong 120g, Olibanum 80g, Radix Gentianae Macrophyllae 80g, Pheretima 120g, Radix Angelicae Sinensis 80g, Poria 220g, Semen Phaseoli 120g, Rhizoma Et Radix Notopterygii 120g, Rhizoma Gastrodiae 80g, Radix Paeoniae Rubra 120g, Herba Asari 120g, Radix Saposhnikoviae 80g, Rhizoma Arisaematis 120g, Ramulus Cinnamomi 80g, Radix Et Rhizoma Nardostachyos 80g, Cinnabaris 130g; Its preparation technology is with embodiment two.
Embodiment five
Medicine of the present invention is made up of Radix Aconiti Preparata 100, the Radix Angelicae Dahuricae 100, Radix Aconiti Kusnezoffii Preparata 100, Rhizoma Cyperi (processed) 100, Radix Glycyrrhizae 100, Rhizoma Atractylodis Macrocephalae (parched) 50, Myrrha (processed) 20, Herba Ephedrae 100, Rhizoma Chuanxiong 100, Olibanum (processed) 50, Radix Gentianae Macrophyllae 50, Pheretima 100, Radix Angelicae Sinensis 50, Poria 200, Semen Phaseoli 100, Rhizoma Et Radix Notopterygii 100, Rhizoma Gastrodiae 50, Radix Paeoniae Rubra 100, Herba Asari 100, Radix Saposhnikoviae 50, Rhizoma Arisaematis (processed) 100, Ramulus Cinnamomi 50, Radix Et Rhizoma Nardostachyos 50, Cinnabaris 80;
The preparation technology who is made into pill is as follows: Cinnabaris is ground into impalpable powder, and standby; Except that Cinnabaris all the other 23 flavor crude drug are ground into thin medicated powder with pulverizer after putting in the agitator tank fully mix homogeneously, and are standby; Mel after overbakingization is poured in the holding vessel, sedimentation 12-24 hour Mel is through coarse filtration and fine straining, pump in the vacuum concentration pan, extremely tender honey is standby for steam pressure 0.05-0.15Mpa, vacuum 0.08-0.09Mpa, temperature 50-60 ℃ vacuum concentration, the water content of tender honey is 18.5-19.5%; Purified water is heated in the dosing bucket boils, the tender honey that adds 1-1.5 times of purified water weight, be stirred to mix homogeneously, be heated to boil refined honey, add refined honey 30-50g with every 100g medicated powder and squeeze ball, with Cinnabaris fine powder coating drying, with Cinnabaris fine powder coating drying process be: the crowded pill of institute is packed in the clean dried dish, every dish loading amount is even, and thickness is no more than 3cm, and room temperature is placed and changed in the heated-air circulation oven again after 35-60 hour, at dry 20-24 below 60 ℃ hour, make moisture≤11.0%, take out and to drop into again in the coating machine, regulate coating machine rotating speed and spray into purified water and make in right amount and be sprinkled into the Cinnabaris powder behind the pill surface wettability and make the pill color and luster even.
Embodiment six
The raw material that medicine of the present invention is made effective ingredient constitutes Radix Aconiti Preparata 50, the Radix Angelicae Dahuricae 150, Radix Aconiti Kusnezoffii Preparata 150, Rhizoma Cyperi 150, Radix Glycyrrhizae 150, the Rhizoma Atractylodis Macrocephalae 80, Myrrha 10, Herba Ephedrae 50, Rhizoma Chuanxiong 50, Olibanum 80, Radix Gentianae Macrophyllae 80, Pheretima 50, Radix Angelicae Sinensis 80, Poria 150, Semen Phaseoli 150, Rhizoma Et Radix Notopterygii 50, Rhizoma Gastrodiae 80, Radix Paeoniae Rubra 150, Herba Asari 150, Radix Saposhnikoviae 80, Rhizoma Arisaematis 50, Ramulus Cinnamomi 80, Radix Et Rhizoma Nardostachyos 30, Cinnabaris 130 by weight.It can adopt common process to make tablet.
Embodiment seven
The raw material that medicine of the present invention is made effective ingredient constitutes Radix Aconiti Preparata 120, the Radix Angelicae Dahuricae 80, Radix Aconiti Kusnezoffii Preparata 80, Rhizoma Cyperi (processed) 80, Radix Glycyrrhizae 80, Rhizoma Atractylodis Macrocephalae (parched) 80, Myrrha (processed) 30, Herba Ephedrae 80, Rhizoma Chuanxiong 80, Olibanum (processed) 80, Radix Gentianae Macrophyllae 30, Pheretima 80, Radix Angelicae Sinensis 30, Poria 160, Semen Phaseoli 80, Rhizoma Et Radix Notopterygii 80, Rhizoma Gastrodiae 80, Radix Paeoniae Rubra 80, Herba Asari 80, Radix Saposhnikoviae 80, Rhizoma Arisaematis (processed) 80, Ramulus Cinnamomi 80, Radix Et Rhizoma Nardostachyos 80, Cinnabaris 60 by weight.Its preparation method is with embodiment five.
Embodiment eight
Medicine of the present invention is made up of Radix Aconiti Preparata 120, the Radix Angelicae Dahuricae 90, Radix Aconiti Kusnezoffii Preparata 88, Rhizoma Cyperi (processed) 98, Radix Glycyrrhizae 115, Rhizoma Atractylodis Macrocephalae (parched) 48, Myrrha (processed) 25, Herba Ephedrae 95, Rhizoma Chuanxiong 95, Olibanum (processed) 65, Radix Gentianae Macrophyllae 65, Pheretima 116, Radix Angelicae Sinensis 60, Poria 218, Semen Phaseoli 90, Rhizoma Et Radix Notopterygii 90, Rhizoma Gastrodiae 45, Radix Paeoniae Rubra 120, Herba Asari 120, Radix Saposhnikoviae 55, Rhizoma Arisaematis (processed) 110, Ramulus Cinnamomi 65, Radix Et Rhizoma Nardostachyos 65, Cinnabaris 80; Its preparation method is with embodiment five.
Claims (5)
1, has expelling wind and removing dampness, the meridian dredging, the Chinese medicine of dispersing cold for relieving pain function is characterized in that the raw material of making effective ingredient constitutes by weight: Radix Aconiti Preparata 50-150, Radix Angelicae Dahuricae 50-150, Radix Aconiti Kusnezoffii Preparata 50-150, Rhizoma Cyperi 50-150, Radix Glycyrrhizae 50-150, Rhizoma Atractylodis Macrocephalae 30-80, Myrrha 10-50, Herba Ephedrae 50-150, Rhizoma Chuanxiong 50-150, Olibanum 30-80, Radix Gentianae Macrophyllae 30-80, Pheretima 50-150, Radix Angelicae Sinensis 30-80, Poria 150-250, Semen Phaseoli 50-150, Rhizoma Et Radix Notopterygii 50-150, Rhizoma Gastrodiae 30-80, Radix Paeoniae Rubra 50-150, Herba Asari 50-150, Radix Saposhnikoviae 30-80, Rhizoma Arisaematis 50-150, Ramulus Cinnamomi 30-80, Radix Et Rhizoma Nardostachyos 30-80, Cinnabaris 60-130.
2, according to claim 1 have an expelling wind and removing dampness, the meridian dredging, the Chinese medicine of dispersing cold for relieving pain function is characterized in that the raw material of making effective ingredient constitutes by weight: Radix Aconiti Preparata 80-120, Radix Angelicae Dahuricae 80-120, Radix Aconiti Kusnezoffii Preparata 80-120, Rhizoma Cyperi 80-120, Radix Glycyrrhizae 80-120, Rhizoma Atractylodis Macrocephalae 30-80, Myrrha 10-30, Herba Ephedrae 80-120, Rhizoma Chuanxiong 80-120, Olibanum 30-80, Radix Gentianae Macrophyllae 30-80, Pheretima 80-120, Radix Angelicae Sinensis 30-80, Poria 160-220, Semen Phaseoli 80-120, Rhizoma Et Radix Notopterygii 80-120, Rhizoma Gastrodiae 30-80, Radix Paeoniae Rubra 80-120, Herba Asari 80-120, Radix Saposhnikoviae 30-80, Rhizoma Arisaematis 80-120, Ramulus Cinnamomi 30-80, Radix Et Rhizoma Nardostachyos 30-80, Cinnabaris 60-130.
3, the Chinese medicine with expelling wind and removing dampness, the meridian dredging, dispersing cold for relieving pain function according to claim 1 is characterized in that the raw material of making effective ingredient constitutes by weight: Radix Aconiti Preparata 100, the Radix Angelicae Dahuricae 100, Radix Aconiti Kusnezoffii Preparata 100, Rhizoma Cyperi (processed) 100, Radix Glycyrrhizae 100, Rhizoma Atractylodis Macrocephalae (parched) 50, Myrrha (processed) 20, Herba Ephedrae 100, Rhizoma Chuanxiong 100, Olibanum (processed) 50, Radix Gentianae Macrophyllae 50, Pheretima 100, Radix Angelicae Sinensis 50, Poria 200, Semen Phaseoli 100, Rhizoma Et Radix Notopterygii 100, Rhizoma Gastrodiae 50, Radix Paeoniae Rubra 100, Herba Asari 100, Radix Saposhnikoviae 50, Rhizoma Arisaematis (processed) 100, Ramulus Cinnamomi 50, Radix Et Rhizoma Nardostachyos 50, Cinnabaris 80.
4, the described Chinese medicine preparation technology with expelling wind and removing dampness, the meridian dredging, dispersing cold for relieving pain function of a kind of claim 1 is characterized in that comprising the steps: described Cinnabaris is ground into impalpable powder, and is standby; Standby after the Rhizoma Atractylodis Macrocephalae parch; Standby after Rhizoma Arisaematis, Myrrha, Rhizoma Cyperi, the Olibanum process of preparing Chinese medicine; Except that Cinnabaris all the other 23 flavor crude drug, wherein the Rhizoma Atractylodis Macrocephalae is after the parch, Rhizoma Arisaematis, Myrrha, Rhizoma Cyperi, Olibanum be for after concocting, put in the agitator tank fully mix homogeneously after, be ground into thin medicated powder with pulverizer, standby; Mel after overbakingization is poured in the holding vessel, sedimentation 12-24 hour Mel is through coarse filtration and fine straining, pump in the vacuum concentration pan, extremely tender honey is standby for steam pressure 0.05-0.15Mpa, vacuum 0.08-0.09Mpa, temperature 50-60 ℃ vacuum concentration, and the water content of tender honey is 18.5-19.5%; Purified water is heated in the dosing bucket boils, and adds the tender honey of 1-1.5 times of purified water weight, is stirred to mix homogeneously, be heated to boil refined honey, add refined honey 30-50g with every 100g medicated powder and squeeze ball, usefulness Cinnabaris fine powder coating drying.
5, the Chinese medicine preparation technology with expelling wind and removing dampness, the meridian dredging, dispersing cold for relieving pain function according to claim 4, it is characterized in that describedly being: the crowded pill of institute is packed in the clean dried dish with Cinnabaris fine powder coating drying, every dish loading amount is even, thickness is no more than 3cm, room temperature is placed and is changed in the heated-air circulation oven again after 35-60 hour, at dry 20-24 below 60 ℃ hour, make moisture≤11.0%, take out and to drop into again in the coating machine, regulate coating machine rotating speed and spray into purified water and make in right amount and be sprinkled into the Cinnabaris powder behind the pill surface wettability and make the pill color and luster even.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100456857A CN100534500C (en) | 2006-01-20 | 2006-01-20 | Chinese medicine with wind-dispelling damp-eliminating, collaterals-dredging, coldness-expelling pain-relieving functions and preparation process thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100456857A CN100534500C (en) | 2006-01-20 | 2006-01-20 | Chinese medicine with wind-dispelling damp-eliminating, collaterals-dredging, coldness-expelling pain-relieving functions and preparation process thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1840101A true CN1840101A (en) | 2006-10-04 |
| CN100534500C CN100534500C (en) | 2009-09-02 |
Family
ID=37029404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100456857A Active CN100534500C (en) | 2006-01-20 | 2006-01-20 | Chinese medicine with wind-dispelling damp-eliminating, collaterals-dredging, coldness-expelling pain-relieving functions and preparation process thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100534500C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101401846B (en) * | 2008-11-09 | 2012-07-04 | 李燕 | Bi-syndrome treating Chinese medicine preparation |
| CN105779115A (en) * | 2016-03-15 | 2016-07-20 | 安徽九禾农业发展有限公司 | Method for preparing wind-expelling cold-removing grape seed edible oil |
| CN111568980A (en) * | 2020-06-23 | 2020-08-25 | 西安岐奥丰医疗发展有限公司 | Chinese medicinal preparation for dispelling wind and eliminating dampness and preparation method thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1679900A (en) | 2005-02-05 | 2005-10-12 | 邓俐丽 | Chinese medicine preparation for treating rheumatosis and arthralgia syndrome making method and quality control thereof |
-
2006
- 2006-01-20 CN CNB2006100456857A patent/CN100534500C/en active Active
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101401846B (en) * | 2008-11-09 | 2012-07-04 | 李燕 | Bi-syndrome treating Chinese medicine preparation |
| CN105779115A (en) * | 2016-03-15 | 2016-07-20 | 安徽九禾农业发展有限公司 | Method for preparing wind-expelling cold-removing grape seed edible oil |
| CN111568980A (en) * | 2020-06-23 | 2020-08-25 | 西安岐奥丰医疗发展有限公司 | Chinese medicinal preparation for dispelling wind and eliminating dampness and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100534500C (en) | 2009-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1768812A (en) | Medicinal composition for removing dampness to relieve itching and its preparation method and uses | |
| CN1836720A (en) | Chinese medicine composition for treating arthritis or gout and preparing method thereof | |
| CN101703684B (en) | Medicament for treating allergic purpura and preparation method thereof | |
| CN1868535A (en) | Medicine composition for treating rheumatic arthritis and rheumatoid arthritis, and its prepn. method | |
| CN1565553A (en) | Dysmenorrhea treating Chinese traditional medicine | |
| CN1726929A (en) | Compsn. of medication for treating diabetes | |
| CN108853433A (en) | A kind of Chinese medicine and preparation method thereof for treating diabetic nephropathy | |
| CN1840101A (en) | Chinese medicine with wind-dispelling damp-eliminating, collaterals-dredging, coldness-expelling pain-relieving functions and preparation process thereof | |
| CN115837065B (en) | Traditional Chinese medicine composition and application thereof | |
| CN1232279C (en) | Antilipemic Chinese medicine | |
| CN1738633A (en) | Anti-obesity ingretients from medicinal plants and their composittion | |
| CN1772257A (en) | Fatty liver treating notoginseng prepn and its prepn process | |
| CN1739678A (en) | Medicine for treating pain caused by wind, cold and wetness evils and its prepn | |
| CN1712055A (en) | Chinese medicinal preparation (litholytic capsule) for treating urinific calculus | |
| CN1274352C (en) | Plaster for treating hyperosteogeny, protrusion of interverterbral disc, arthritis and periarthritis of shoulder joint and its prepn. | |
| CN101032540A (en) | Medicine composition for curing arthritis and the preparing method and purpose thereof | |
| CN1186067C (en) | Medicine for curing acute injury of muscle and tendon and its preparation method | |
| CN1148217C (en) | Chinese medicine for treating chronic bronchitis | |
| CN1927282A (en) | Preparation for treating arthritis and preparation method thereof | |
| CN101057945A (en) | Traditional Chinese medicine for treating digestive cancer and its producing method | |
| CN104645144A (en) | Traditional Chinese medicine preparation for treating nephritis and preparation method of traditional Chinese medicine preparation | |
| CN108904617A (en) | The pharmaceutical composition and its preparation method and application for treating cranial vascular disease | |
| CN1304045C (en) | Arthralgia removing pills and their preparation | |
| CN1768797A (en) | Chinese medicine for treating star-like cataract caused by viral keratitis and preparation method thereof | |
| CN1416879A (en) | Antilipemic Chinese medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: SHENYANG HONGYAO PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHENYANG CHINESE MEDICINE PHARMACEUTICAL CO., LTD. Effective date: 20080307 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20080307 Address after: Liaoning province Shenyang City District City Road No. 2 post encoding: 110044 Applicant after: Shenyang Hongyao Pharmaceutical Co., Ltd. Address before: Liaoning province Shenyang City District City Road No. 2 post encoding: 110044 Applicant before: Shenyang Chinese Medicine Pharmaceutical Co., Ltd. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20111130 Address after: 110044 Liaoning Province, Shenyang City District City Road No. 2 Patentee after: Shenyang Hongyao Pharmaceutical Co., Ltd. Address before: 110044 Liaoning Province, Shenyang City District City Road No. 2 Patentee before: Shenyang Hongyao Pharmaceutical Co., Ltd. |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20140506 Address after: 110044 Liaoning Province, Shenyang City District City Road No. 2 Patentee after: SHENYANG HONGYAO GROUP CO., LTD. Address before: 110044 Liaoning Province, Shenyang City District City Road No. 2 Patentee before: Shenyang Hongyao Pharmaceutical Co., Ltd. |